Compare AVAH & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVAH | LMAT |
|---|---|---|
| Founded | 1984 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2021 | 2006 |
| Metric | AVAH | LMAT |
|---|---|---|
| Price | $9.26 | $83.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $10.19 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 1.2M | 194.1K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | N/A | ★ 27.40 |
| EPS | 0.37 | ★ 2.32 |
| Revenue | ★ $2,290,591,000.00 | $240,866,000.00 |
| Revenue This Year | $17.31 | $16.27 |
| Revenue Next Year | $6.78 | $8.61 |
| P/E Ratio | ★ $25.42 | $35.76 |
| Revenue Growth | ★ 15.48 | 13.07 |
| 52 Week Low | $3.67 | $71.42 |
| 52 Week High | $10.32 | $107.23 |
| Indicator | AVAH | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 56.31 | 37.75 |
| Support Level | $8.26 | $81.81 |
| Resistance Level | $8.58 | $89.43 |
| Average True Range (ATR) | 0.30 | 3.10 |
| MACD | 0.06 | -0.49 |
| Stochastic Oscillator | 86.07 | 11.21 |
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.